|
Best Pharmaceuticals for Children Act (BPCA)
|
NHD12014-001-01164
|
$2,351,618
|
$2,351,618
|
N/A
|
NICHD-NATIONAL INSTITUTE OF CH
|
|
NCI - OBSSR NOD18002-001-00003
|
NOD18002-001
|
$125,000
|
$125,000
|
N/A
|
OD-OFFICE OF THE DIRECTOR
|
|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$108,000
|
N/A
|
National Institutes of Health
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$679,649
|
$679,649
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Li-Fraumeni Syndrome in Brazil
|
ZIA CP010144 10769
|
$53,072
|
$10,614
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
$13,998
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$2,256,906
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-05
|
$192,024
|
$192,024
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$20,853,800
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
$190,688
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
$228,767
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
$227,935
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
$630,740
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$1,652,758
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$4,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Developing Human Induced Pluripotent Stem Cell Precision Oncology Models
|
1R50CA233164-01
|
$155,981
|
$155,981
|
ANASTASAKI, CORINA
|
WASHINGTON UNIVERSITY
|
|
General Descriptive Studies
|
ZIA CP010183 00350
|
$1,090,047
|
$109,005
|
Anderson, William
|
DCEG (NCI)
|
|
Descriptive studies of cancer and mortality
|
ZIA CP010150 10763
|
$42,401
|
$8,480
|
Apelberg, Meredith
|
DCEG (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$437,122
|
$437,122
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
$187,338
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$62,446
|
$24,978
|
Aplan, Peter
|
CCR (NCI)
|
|
Elucidating transcription regulation by epigenetics in neuroblastoma
|
1K08CA226237-01
|
$206,394
|
$206,394
|
APPLEBAUM, MARK
|
UNIVERSITY OF CHICAGO
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
$254,821
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
$604,525
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
$404,076
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
$120,439
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-10
|
$491,462
|
$491,462
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$4,218,764
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$2,485
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$1,715
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$33,345
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$19,950
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$198,400
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$636,350
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$6,720
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$16,519
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$20,627
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma
|
1R21CA229919-01
|
$213,694
|
$213,694
|
ASNAGHI, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
O-GlcNAcylation of Ewing sarcoma proteins in chromosomal maintenance
|
1R03CA223949-01
|
$89,000
|
$89,000
|
AZUMA, MIZUKI
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Novel ODC Inhibitor Phaseolotoxin in Neuroblastoma
|
1R21CA216867-01A1
|
$193,750
|
$193,750
|
BACHMANN, ANDRE
|
MICHIGAN STATE UNIVERSITY
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
$71,707
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$183,605
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$10,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$5,449
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$3,028
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$1,271
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Childhood Cancers for this search: $302,325,670
|